Skip to main content
Search
Main content
Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

HIV medicine
Published

Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART

Authors
Merle Henderson, Peter Dutey-Magni, Carolina Herrera, Wolfgang Stöhr, Alejandro Arenas-Pinto, Owen Swann, Amanda Heslegrave, Henrik Zetterberg, John Tregoning, Sarah Fidler, François Raffi, Andrea Calcagno, Ab Babiker, Alan Winston
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation

Authors
Burak Arslan, Johan Gobom, Ulf Andreasson, Laia Montoliu-Gaya, Andrea L Benedet, Anna Dittrich, Silke Kern, Ingmar Skoog, Nicholas J Ashton, Tevy Chan, Nesrine Rahmouni, Pedro Rosa-Neto, Kaj Blennow, Henrik Zetterberg, Hlin Kvartsberg
Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation
EBioMedicine
Published

Biomarkers of Alzheimer's disease pathophysiology and delirium

Authors
Kristi Henjum, Bjørn Erik Neerland, Kaj Blennow, Henrik Zetterberg, Christian Thomas Pollmann, Roy Bjørkholt Olsen, Lene Solberg, Marius Myrstad, Olav Tobias Ødegaard, Adi Karabeg, Alan Gulestøl, Ane Victoria Idland, Leiv Otto Watne
Biomarkers of Alzheimer's disease pathophysiology and delirium

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia